Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
Published in
HIV clinical trials, vol. 15, no. 3, p. 92-103Publication date
2014Abstract
Keywords
- CD4
- Antiretroviral therapy
- Epidemiology
- Protease inhibitors
- Reverse transcriptase inhibitors
- Viral load
- Adult
- Alkynes
- Atazanavir Sulfate
- Benzoxazines / administration & dosage
- CD4 Lymphocyte Count
- Cohort Studies
- Cyclopropanes
- Drug Therapy, Combination
- Female
- HIV Infections / drug therapy
- HIV Infections / immunology
- HIV Infections / virology
- Humans
- Male
- Oligopeptides / administration & dosage
- Prospective Studies
- Pyridines / administration & dosage
- Ritonavir / administration & dosage
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
WANG, Qing et al. Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. In: HIV clinical trials, 2014, vol. 15, n° 3, p. 92–103. doi: 10.1310/hct1503-92
Main files (1)
Article (Published version)
Identifiers
- PID : unige:173237
- DOI : 10.1310/hct1503-92
- PMID : 24947533
